Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bosutinib-related pneumonitis.
Jutant EM, Meignin V, Montani D, Tazi A, Rousselot P, Bergeron A. Jutant EM, et al. Among authors: rousselot p. Eur Respir J. 2017 Sep 12;50(3):1700930. doi: 10.1183/13993003.00930-2017. Print 2017 Sep. Eur Respir J. 2017. PMID: 28899936 Free article. No abstract available.
Hypersensitivity pneumonitis related to imatinib mesylate.
Bergeron A, Bergot E, Vilela G, Ades L, Devergie A, Espérou H, Socié G, Calvo F, Gluckman E, Ribaud P, Rousselot P, Tazi A. Bergeron A, et al. Among authors: rousselot p. J Clin Oncol. 2002 Oct 15;20(20):4271-2. doi: 10.1200/JCO.2002.99.179. J Clin Oncol. 2002. PMID: 12377975 No abstract available.
Bone marrow histological patterns can predict survival of patients with grade 1 or 2 follicular lymphoma: a study from the Groupe d'Etude des Lymphomes Folliculaires.
Canioni D, Brice P, Lepage E, Chababi M, Meignin V, Salles B, Xerri L, Péaud PY, Rousselot P, Peuchmaur M, Solal-Céligny P, Brousse N; Groupe d'Etude des Lymphomes Folliculaires. Canioni D, et al. Among authors: rousselot p. Br J Haematol. 2004 Aug;126(3):364-71. doi: 10.1111/j.1365-2141.2004.05046.x. Br J Haematol. 2004. PMID: 15257708 Free article.
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.
Guignabert C, Phan C, Seferian A, Huertas A, Tu L, Thuillet R, Sattler C, Le Hiress M, Tamura Y, Jutant EM, Chaumais MC, Bouchet S, Manéglier B, Molimard M, Rousselot P, Sitbon O, Simonneau G, Montani D, Humbert M. Guignabert C, et al. Among authors: rousselot p. J Clin Invest. 2016 Sep 1;126(9):3207-18. doi: 10.1172/JCI86249. Epub 2016 Aug 2. J Clin Invest. 2016. PMID: 27482885 Free PMC article. Clinical Trial.
Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors.
Weatherald J, Bondeelle L, Chaumais MC, Guignabert C, Savale L, Jaïs X, Sitbon O, Rousselot P, Humbert M, Bergeron A, Montani D. Weatherald J, et al. Among authors: rousselot p. Eur Respir J. 2020 Oct 29;56(4):2000279. doi: 10.1183/13993003.00279-2020. Print 2020 Oct. Eur Respir J. 2020. PMID: 32527740 Free article. Review.
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients.
Rousselot P, Mollica L, Guilhot J, Guerci A, Nicolini FE, Etienne G, Legros L, Charbonnier A, Coiteux V, Dartigeas C, Escoffre-Barbe M, Roy L, Cony-Makhoul P, Dubruille V, Gardembas M, Huguet F, Réa D, Cayssials E, Guilhot F, Bergeron A, Molimard M, Mahon FX, Cayuela JM, Busque L, Bouchet S. Rousselot P, et al. Br J Haematol. 2021 Jul;194(2):393-402. doi: 10.1111/bjh.17654. Epub 2021 Jun 30. Br J Haematol. 2021. PMID: 34195988 Clinical Trial.
The rising prevalence of chronic myeloid leukemia in France.
Delord M, Foulon S, Cayuela JM, Rousselot P, Bonastre J. Delord M, et al. Among authors: rousselot p. Leuk Res. 2018 Jun;69:94-99. doi: 10.1016/j.leukres.2018.04.008. Epub 2018 Apr 17. Leuk Res. 2018. PMID: 29734071
309 results